Treatment
Treatment literacy materials that cover the basics of hepatitis C treatment, research on efficacy in different key populations, and global treatment uptake.
Materials in this section
Immunodeficiency, Injection Drug Use Linked to Failed HCV Treatment in People with HIV
DAAs achieve a 95% success rate in treating HCV among HIV patients, but 5% experience unsuccessful treatment; Lower CD4 cell counts, HCV genotype 4, and recent injection drug use are linked to higher odds of unsuccessful treatment. More
Preferences and Feasibility of Long-Acting Technologies for the Treatment of Hepatitis C - A Survey of Patients
A study explores the challenges and opportunities in long-acting HCV treatment across three LMICs: Egypt, Ethiopia and India. More
Preferences and Feasibility of Long-Acting Technologies for the Treatment of Hepatitis C - A Survey of Providers and Policymakers
A study explores the acceptability and feasibility of long-acting HCV treatment in LMICs by surveying HCV treatment prescribers and policymakers. More
Efficacy of 8-Week Daclatasvir-Sofosbuvir Regimen for Chronic Hepatitis C
Results suggest a shorter treatment duration could reduce costs and improve access in low- and middle-income countries. More
Artificial Intelligence-Assisted Identification and Retrieval of HCV Patients Lost to Follow-up in Spain
A study identified and relinked to care HCV patients previously lost to medical follow-up in Spain using an artificial intelligence-assisted system. More
Staff-Facilitated Telemedicine Care Delivery for Treatment of Hepatitis C among People Who Inject Drugs
A study measures the acceptability, feasibility, and safety of an urban point-of-diagnosis HCV treatment initiation approach delivered in a non-clinical community setting, through a novel staff-facilitated telemedicine model. More
Model Says Treating Only 75 of 1000 PWID Would Eliminate HCV in This Group
If at least 7.5% of people who inject drugs in the Chicago area use direct-acting antivirals, HCV would be eliminated from that population in 10 years. More
Advancing Hepatitis C Treatment in Sub-Saharan Africa
Findings from the TAC ANRS 12311 trial revealed the success of tailored treatment combinations to the specific genotype of HCV to optimize efficacy and minimize adverse effects. More
Increased Social Support Linked to HCV Status Awareness, Treatment Uptake
Access to care, health insurance, and social support systems were associated with increased hepatitis C virus awareness and treatment among individuals with a history of injection drug use. More
JAMA Paper: In People with Opioid Use Disorder, Telemedicine Treatment for HCV Was More Than Twice as Successful as Off-Site Referral
The study is one of only a few randomized controlled trials that have been conducted to determine the effectiveness of using telemedicine to improve health care access for vulnerable populations. More
